PLoS ONE (Jan 2011)

Role of microRNA-26b in glioma development and its mediated regulation on EphA2.

  • Ning Wu,
  • Xiangzhong Zhao,
  • Ming Liu,
  • Haizhou Liu,
  • Weicheng Yao,
  • Yuyan Zhang,
  • Shousong Cao,
  • Xiukun Lin

DOI
https://doi.org/10.1371/journal.pone.0016264
Journal volume & issue
Vol. 6, no. 1
p. e16264

Abstract

Read online

BackgroundMicroRNAs (miRNAs) are short, non-coding RNAs that regulate the expression of multiple target genes. Deregulation of miRNAs is common in human tumorigenesis. Low level expression of miR-26b has been found in glioma cells. However, its underlying mechanism of action has not been determined.Methodology/principal findingsReal-time PCR was employed to measure the expression level of miR-26b in glioma patients and cells. The level of miR-26b was inversely correlated with the grade of glioma. Ectopic expression of miR-26b inhibited the proliferation, migration and invasion of human glioma cells. A binding site for miR-26b was identified in the 3'UTR of EphA2. Over-expression of miR-26b in glioma cells repressed the endogenous level of EphA2 protein. Vasculogenic mimicry (VM) experiments were performed to further confirm the effects of miR-26b on the regulation of EphA2, and the results showed that miR-26b inhibited the VM processes which regulated by EphA2.SignificanceThis study demonstrated that miR-26b may act as a tumor suppressor in glioma and it directly regulates EphA2 expression. EphA2 is a direct target of miR-26b, and the down-regulation of EphA2 mediated by miR-26b is dependent on the binding of miR-26b to a specific response element of microRNA in the 3'UTR region of EphA2 mRNA.